FDA Approves PYZCHIVA ® (ustekinumab-ttwe), Samsung Bioepis’ Biosimilar to Stelara
“The FDA approval of PYZCHIVA as a biosimilar to Stelara [...]
Valneva Receives Marketing Authorization in Europe for the World’s First Chikungunya Vaccine, IXCHIQ ®
IXCHIQ ® is the world’s only licensed chikungunya vaccine available [...]
OSE Immunotherapeutics Announces Publication of Preclinical Efficacy Results with Lusvertikimab in Acute Lymphoblastic Leukemia in the Journal ‘Blood’
Nicolas Poirier, Chief Executive Officer of OSE Immunotherapeutics, concludes: “We [...]
LIfT BioSciences Appoints Antonin (Tony) de Fougerolles as Chairman of its Board of Directors
Alex Blyth, Chief Executive Officer of LIfT BioSciences commented: “On [...]
Study: Private Equity Acquisitions in Cardiology on the Rise
“Policymakers and clinicians have raised concern about the growing presence [...]
Wondering How to Prevent Running Injuries? Here’s What You Need to Know
To prevent running injuries, you must be proactive—understanding your body, [...]
Bio-Rad Launches Celselect Slides 2.0 to Advance Rare Cell and Circulating Tumor Cell Enrichment for Cancer Research
“CTCs are rare — as low as only 1–10 can [...]
UltraSight Joins Butterfly Garden to Expand AI Real-Time Guidance Across Point of Care Ultrasound Devices
“We are thrilled to partner with UltraSight to bring their [...]
Neuromod Partners with 14 New US Tinnitus Clinics to Expand Availability of FDA Approved Lenire
Lenire has become the most in-demand tinnitus treatment device in [...]
Assessing Industry Impact of FDA’s LDT Final Rule
The recent final rule that recognizes LDTs as regulated medical [...]